Covered recipient · General Payments record
DEBRA R TARANTINO
Allopathic & Osteopathic Physicians Colon & Rectal Surgery
General Payments · PY2018–2024
$2,303.84
- Reported across 58 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Travel and Lodging | $728.08 | 3 |
| Food and Beverage | $667.91 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Axonics Modulation Technologies, Inc. | $1,057.51 | 8 |
| Kerecis Limited | $249.77 | 3 |
| Olympus America Inc. | $29.82 | 1 |
| Exact Sciences Corporation | $27.52 | 1 |
| VERTEX PHARMACEUTICALS INCORPORATED | $15.78 | 1 |
| Ferring Pharmaceuticals Inc. | $15.59 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Axonics, Inc. | $292.81 | 02/09/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1142370344 | CMS |
| Axonics, Inc. | $315.27 | 02/09/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1142370346 | CMS |
| Axonics, Inc. | $155.00 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142370348 | CMS |
| Axonics, Inc. | $120.00 | 02/09/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1142370356 | CMS |
| Axonics, Inc. | $47.74 | 02/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142370350 | CMS |
| Axonics, Inc. | $71.81 | 02/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142370352 | CMS |
| Axonics, Inc. | $27.44 | 02/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142370354 | CMS |
| Axonics, Inc. | $27.44 | 02/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142370358 | CMS |
| Exact Sciences Corporation | $27.52 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114928226 | CMS |
| Ferring Pharmaceuticals Inc. | $15.59 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137514434 | CMS |
| Kerecis Limited | $81.29 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120093239 | CMS |
| Kerecis Limited | $109.65 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120113129 | CMS |
| Kerecis Limited | $58.83 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120106381 | CMS |
| Olympus America Inc. | $29.82 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108473468 | CMS |
| VERTEX PHARMACEUTICALS INCORPORATED | $15.78 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105914164 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.